HB 2199 Arizona House · 57th Legislature - First Regular Session

prescription drugs; advertising; requirements

HB 2199 requires that advertisements for prescription and nonprescription drugs on TV, radio, or online must clearly present major side effects and usage restrictions ("major statement") at the same volume, clarity, and pace as the rest of the ad. It prohibits using distracting audio or visual elements that could interfere with understanding these critical health details. The bill directly affects drug manufacturers and advertisers operating in Arizona. If passed, it would mandate that health risks are communicated as prominently as promotional content in digital and broadcast ads.
Bill status introduced 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 21, 2025 Last action Jan 22, 2025